Cullinan oncology to participate in upcoming investor conferences

Cambridge, mass., nov. 01, 2022 (globe newswire) -- cullinan oncology, inc. (nasdaq: cgem) (“cullinan oncology”) a biopharmaceutical company focused on modality-agnostic targeted oncology for patients with cancer, today announced that its management team will participate in the following investor conferences.
CGEM Ratings Summary
CGEM Quant Ranking